deltatrials
Completed NA NCT02694874

Rosiglitazone Adjunctive Therapy for Severe Malaria in Children

Sponsor: Barcelona Institute for Global Health

Conditions Malaria
Interventions Placebo Rosiglitazone
Updated 11 times since 2017 Last updated: Feb 20, 2024 Started: Feb 29, 2016 Primary completion: Mar 31, 2020 Completion: Dec 31, 2021

A NA clinical study on Malaria, this trial is completed. The trial is conducted by Barcelona Institute for Global Health and has accumulated 11 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2024 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  4. Feb 2023 — Mar 2024 [monthly]

    Unknown Status NA

    Status: Active Not Recruiting → Unknown Status

  5. Feb 2021 — Feb 2023 [monthly]

    Active Not Recruiting NA

▶ Show 6 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting NA

  2. Jun 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  3. May 2020 — Jun 2020 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  4. Nov 2019 — May 2020 [monthly]

    Recruiting NA

  5. Jun 2018 — Nov 2019 [monthly]

    Recruiting NA

  6. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barcelona Institute for Global Health
  • Centro de Investigacao em Saude de Manhica
  • University Health Network, Toronto
Data source: Centro de Investigacao em Saude de Manhica

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Manhiça, Mozambique